Episode notes
The ASH 2024 wrap-up is here! We’re spotlighting the most impactful developments, including menin inhibitors redefining AML treatment, promising gene-editing therapies for sickle cell disease, and next-gen CAR-T advances. Don’t miss this final episode!
Like what you hear? Download Curie from the App store for personalized insights.
Keywords
HealthcareMedicineDeepdivePodcastASHASH2024Oncologyhematology